Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Gritstone Oncology Inc. (NASDAQ : GRTS ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.
Quote
| Last: | $0.0322 |
|---|---|
| Change Percent: | -25.16% |
| Open: | $0.0403 |
| Close: | $0.0322 |
| High: | $0.0403 |
| Low: | $0.031 |
| Volume: | 61,017,982 |
| Last Trade Date Time: | 10/21/2024 03:00:00 am |
Stock Data
| Market Cap: | $3,803,112 |
|---|---|
| Float: | 111,837,482 |
| Insiders Ownership: | 2.7% |
| Institutions: | 11 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.gritstonebio.com |
| Country: | US |
| City: | Emeryville |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Gritstone Oncology Inc. (NASDAQ: GRTS).
